Literature DB >> 12476288

Early infections in adult patients undergoing unrelated donor cord blood transplantation.

S Saavedra1, G F Sanz, I Jarque, F Moscardó, C Jiménez, I Lorenzo, G Martín, J Martínez, J De La Rubia, R Andreu, S Mollá, I Llopis, M J Fernández, M Salavert, B Acosta, M Gobernado, M A Sanz.   

Abstract

Early transplant-related mortality after cord blood transplantation from unrelated donors (UD-CBT) is close to 50%, mainly due to infectious complications. We have studied the incidence and characteristics of early infections (before day 100) in a series of 27 adult patients (median age 30 years, range 16-46) undergoing UD-CBT at a single institution. All 27 patients experienced at least one infectious episode and 18 (66%) suffered a severe infection. Bacteremia occurred in 55% of patients (13 with Gram-positive and 11 with Gram-negative microorganisms). Eleven of 19 CMV-seropositive patients (58%) developed CMV antigenemia and one patient had CMV disease. Fungal infections were documented in three patients (11%), comprising invasive fungal infections in two cases and a localized esophagitis in one. Ten patients (37%) died before day 100 after transplantation. Infection was considered the primary cause of death in four patients (sepsis by Acinetobacter spp. bacteremia in three cases) and contributed to death in another four. The most striking findings in this series were the high incidence of, and mortality due to multiresistant Acinetobacter spp. and the low incidence of and lack of mortality due to CMV disease. This report confirms that infection is a major complication in adults undergoing UD-CBT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12476288     DOI: 10.1038/sj.bmt.1703764

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

1.  Late infectious complications after cord blood stem cell transplantation.

Authors:  N G Almyroudis; J Fabian; T Hahn; B H Segal; M Wetzler; P L McCarthy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-12       Impact factor: 3.267

Review 2.  Umbilical cord blood graft engineering: challenges and opportunities.

Authors:  P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

3.  Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.

Authors:  R Parody; R Martino; R de la Cámara; A García-Noblejas; A Esquirol; I Garcia-Cadenas; T Villaescusa; D Caballero; M Rovira; F Fernandez-Avilés; F J Marquez-Malaver; I Espigado; C Castilla-Llorente; I Heras; M A Cabero; J R Cabrera; P Barba; D Valcarcel; I Sánchez-Ortega; R F Duarte; D Serrano; F Carretero; L Vazquez
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

4.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

5.  Death by edible mushroom: first report of Volvariella volvacea as an etiologic agent of invasive disease in a patient following double umbilical cord blood transplantation.

Authors:  R B Salit; Y R Shea; J Gea-Banacloche; G A Fahle; M Abu-Asab; J A Sugui; A E Carpenter; M M Quezado; M R Bishop; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

6.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

7.  Escherichia coli up-regulates proinflammatory cytokine expression in granulocyte/macrophage lineages of CD34 stem cells via p50 homodimeric NF-kappaB.

Authors:  J M Kim; Y-K Oh; Y-J Kim; J Youn; M-J Ahn
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.

Authors:  Akira Tomonari; Satoshi Takahashi; Jun Ooi; Nobuhiro Tsukada; Takaaki Konuma; Takeshi Kobayashi; Aki Sato; Kashiya Takasugi; Tohru Iseki; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

9.  Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation.

Authors:  Takashi Abe; Tatsuo Furukawa; Masayoshi Masuko; Atsunori Sugimoto; Kiyoshi Okazuka; Keiichiro Honma; Takeo Fujimura; Seitaro Iguchi; Shinichi Nishi; Mitsuhiro Ueno; Masayuki Nagahashi; Gen Watanabe; Yoichi Ajioka; Noriatsu Isahai; Koichi Nagai; Yukumasa Kazuyama; Yosifusa Aizawa
Journal:  Int J Hematol       Date:  2009-09-11       Impact factor: 2.490

10.  Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.

Authors:  Jeff K Davies; John G Gribben; Lisa L Brennan; Dongin Yuk; Lee M Nadler; Eva C Guinan
Journal:  Blood       Date:  2008-07-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.